Curran Terrie
Insider CIK 1690298 · MYOV Director · PHAT President and Chief Executive, Director · ARQT Director · CELG See remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics, I | M Exercise deriv | 2026-08-27 | 2026-08-28 | 27,052 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise deriv | 2026-08-27 | 2026-08-28 | 11,148 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-08-27 | 2026-08-28 | 27,052 | $25.03 | $677.1K | 23,526 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise | 2026-08-27 | 2026-08-28 | 11,148 | $7.51 | $83.7K | 34,674 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-08-27 | 2026-08-28 | 11,148 | $25.03 | $279.0K | 23,526 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise | 2026-08-27 | 2026-08-28 | 27,052 | $8.63 | $233.5K | 50,578 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise deriv | 2026-08-27 | 2026-08-28 | 27,052 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise deriv | 2026-08-27 | 2026-08-28 | 11,148 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-08-27 | 2026-08-28 | 27,052 | $25.03 | $677.1K | 23,526 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise | 2026-08-27 | 2026-08-28 | 27,052 | $8.63 | $233.5K | 50,578 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-08-27 | 2026-08-28 | 11,148 | $25.03 | $279.0K | 23,526 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise | 2026-08-27 | 2026-08-28 | 11,148 | $7.51 | $83.7K | 34,674 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise deriv | 2026-08-20 | 2026-08-24 | 1,072 | — | $0 | 11,148 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-08-20 | 2026-08-24 | 1,072 | $26.04 | $27.9K | 23,526 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise | 2026-08-20 | 2026-08-24 | 1,072 | $7.51 | $8.1K | 24,598 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise deriv | 2026-08-20 | 2026-08-24 | 1,072 | — | $0 | 11,148 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-08-20 | 2026-08-24 | 1,072 | $26.04 | $27.9K | 23,526 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise | 2026-08-20 | 2026-08-24 | 1,072 | $7.51 | $8.1K | 24,598 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2026-06-05 | 2026-06-09 | 16,667 | — | $0 | 16,667 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2026-06-05 | 2026-06-09 | 5,778 | — | $0 | 23,526 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2025-06-12 | 2025-06-16 | 20,568 | — | $0 | 20,568 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2025-06-12 | 2025-06-16 | 7,609 | — | $0 | 17,748 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-02-27 | 2025-03-03 | 342,500 | — | $0 | 342,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2025-01-21 | 2025-01-23 | 19,109 | $6.59 | $125.9K | 360,465 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-11-11 | 2024-11-13 | 8,687 | $10.85 | $94.3K | 10,139 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2024-07-15 | 2024-07-17 | 33,848 | $11.72 | $396.7K | 377,734 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2024-06-14 | 2024-06-18 | 27,052 | — | $0 | 27,052 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-06-14 | 2024-06-18 | 10,139 | — | $0 | 18,826 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2024-03-22 | 2024-03-26 | 16,851 | $9.11 | $153.5K | 410,784 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2024-01-18 | 2024-01-22 | 475,000 | — | $0 | 475,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-11-01 | 2023-11-03 | 37,500 | — | $0 | 427,171 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | D To issuer deriv | 2023-07-14 | 2023-07-17 | 175,000 | — | $0 | 0 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | D To issuer deriv | 2023-07-14 | 2023-07-17 | 225,000 | — | $0 | 0 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-07-14 | 2023-07-17 | 200,000 | — | $0 | 389,671 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2023-05-31 | 2023-06-02 | 12,220 | — | $0 | 12,220 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-05-31 | 2023-06-02 | 4,375 | — | $0 | 8,687 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | P Buy | 2023-04-06 | 2023-04-07 | 12,919 | $7.82 | $101.0K | 188,290 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 33,846 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 21,096 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 21,603 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 5,250 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 22,500 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 22,500 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 11,154 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer | 2023-03-10 | 2023-03-10 | 3,673 | — | $0 | 0 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-03-01 | 2023-03-03 | 1,436 | $8.54 | $12.3K | 175,371 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-01-20 | 2023-01-20 | 5,821 | $8.20 | $47.7K | 176,807 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2023-01-19 | 2023-01-20 | 162,500 | — | $0 | 162,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-01-19 | 2023-01-20 | 97,500 | — | $0 | 182,628 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2022-11-21 | 2022-11-23 | 1,526 | $9.60 | $14.6K | 83,720 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award | 2022-10-26 | 2022-10-28 | 9,859 | — | $0 | 9,859 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2022-09-01 | 2022-09-02 | 7,500 | — | $0 | 85,246 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2022-06-01 | 2022-06-03 | 11,796 | — | $0 | 11,796 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2022-06-01 | 2022-06-03 | 4,312 | — | $0 | 4,312 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2022-05-19 | 2022-05-20 | 12,000 | — | $0 | 76,595 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | P Buy | 2022-05-13 | 2022-05-16 | 20,500 | $7.41 | $151.9K | 64,595 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2022-01-19 | 2022-01-21 | 206,250 | — | $0 | 206,250 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2022-01-19 | 2022-01-21 | 41,250 | — | $0 | 44,095 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2021-11-05 | 2021-11-09 | 21,096 | — | $0 | 21,096 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2021-09-09 | 2021-09-13 | 4,850 | — | $0 | 5,250 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2021-09-09 | 2021-09-13 | 4,850 | $7.65 | $37.1K | 4,850 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2021-09-09 | 2021-09-13 | 4,850 | $25.58 | $124.1K | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2021-09-02 | 2021-09-03 | 37,135 | — | $0 | 10,100 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2021-09-02 | 2021-09-03 | 37,135 | $25.03 | $929.5K | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2021-09-02 | 2021-09-03 | 37,135 | $7.65 | $284.1K | 37,135 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2021-09-01 | 2021-09-03 | 11,373 | — | $0 | 47,235 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2021-09-01 | 2021-09-03 | 11,373 | $25.00 | $284.3K | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2021-09-01 | 2021-09-03 | 11,373 | $7.65 | $87.0K | 11,373 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2021-06-09 | 2021-06-11 | 13,391 | — | $0 | 13,391 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | M Exercise deriv | 2021-03-22 | 2021-03-23 | 11,513 | — | $0 | 855,687 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | M Exercise | 2021-03-22 | 2021-03-23 | 11,513 | $6.95 | $80.0K | 11,513 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-03-22 | 2021-03-23 | 10,373 | $43.24 | $448.5K | 1,140 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-03-22 | 2021-03-23 | 1,140 | $44.08 | $50.3K | 0 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-01-29 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2020-11-02 | 2020-11-04 | 37,500 | — | $0 | 37,500 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2020-09-15 | 2020-09-17 | 21,603 | — | $0 | 21,603 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2020-07-01 | 2020-07-02 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,776 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,562 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 2,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 2,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 2,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 2,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 5,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 7,050 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 5,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,750 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 5,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 12,983 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 12,983 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 12,982 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,777 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 15,659 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,563 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,776 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,593 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 4,120 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 27,749 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 1,857 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,426 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award | 2019-11-20 | 2019-11-22 | 9,889 | — | $0 | 19,341 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award | 2019-11-20 | 2019-11-22 | 5,139 | — | $0 | 9,452 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award | 2019-11-20 | 2019-11-22 | 17,840 | — | $0 | 37,181 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 37,181 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 327 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-10-31 | 2019-11-04 | 3,281 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2019-10-31 | 2019-11-04 | 1,123 | $108.03 | $121.3K | 4,313 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-10-31 | 2019-11-04 | 3,281 | — | $0 | 5,436 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-09-18 | 2019-09-19 | 4,500 | — | $0 | 2,072 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2019-09-18 | 2019-09-19 | 4,500 | $98.20 | $441.9K | 8,993 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2019-09-18 | 2019-09-19 | 6,838 | $98.31 | $672.2K | 2,155 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-09-18 | 2019-09-19 | 4,500 | $58.33 | $262.5K | 13,493 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2019-08-23 | 2019-08-27 | 58,608 | — | $0 | 58,608 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-05-02 | 2019-05-06 | 1,563 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-05-02 | 2019-05-06 | 1,563 | — | $0 | 9,483 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2019-05-02 | 2019-05-06 | 490 | $95.21 | $46.7K | 8,993 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2019-03-01 | 2019-03-05 | 27,749 | — | $0 | 27,749 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2019-02-04 | 2019-02-06 | 4,120 | — | $0 | 4,120 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-12-16 | 2018-12-18 | 2,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-12-16 | 2018-12-18 | 2,500 | — | $0 | 9,151 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2018-12-16 | 2018-12-18 | 1,231 | $68.20 | $84.0K | 7,920 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-10-29 | 2018-10-31 | 12,983 | — | $0 | 12,983 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2018-08-31 | 2018-09-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-07-30 | 2018-08-01 | 12,983 | — | $0 | 12,983 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-05-08 | 2018-05-17 | 6,593 | — | $0 | 6,593 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-05-08 | 2018-05-17 | 12,982 | — | $0 | 12,982 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-05-04 | 2018-05-08 | 2,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2018-05-04 | 2018-05-08 | 856 | $86.89 | $74.4K | 6,651 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-05-04 | 2018-05-08 | 2,500 | — | $0 | 7,507 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-01-29 | 2018-01-31 | 6,777 | — | $0 | 6,777 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-12-19 | 2017-12-20 | 1,765 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-12-19 | 2017-12-20 | 1,765 | — | $0 | 5,690 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2017-12-19 | 2017-12-20 | 683 | $107.06 | $73.1K | 5,007 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-10-30 | 2017-10-31 | 15,659 | — | $0 | 15,659 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-10-30 | 2017-10-31 | 1,857 | — | $0 | 1,857 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2017-09-25 | 2017-09-26 | 1,727 | $143.89 | $248.5K | 3,925 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2017-08-18 | 2017-10-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-08-01 | 2017-08-02 | 1,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-08-01 | 2017-08-02 | 1,500 | — | $0 | 6,210 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2017-08-01 | 2017-08-02 | 558 | $135.18 | $75.4K | 5,652 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-07-31 | 2017-08-02 | 6,776 | — | $0 | 6,776 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2017-05-15 | 2017-05-17 | 11,154 | — | $0 | 11,154 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2016-11-15 | 2016-11-17 | 33,846 | — | $0 | 33,846 | SEC↗ |